Qishen Yiqi Formula not only inhibits the NF-B pathway to reduce inflammatory responses, but also regulates metabolic reprogramming of PASMCs through the HIF-1 signaling pathway to inhibit glycolysis-related proliferation
As such, this can cause an increased susceptibility to many age-related conditions and diseaseswhich includes the aging process itself, metabolic deficiencies, as well as chronic age-related diseases, such as cataracts, hearing impairment, and glaucoma, to name a few
Drugs like semaglutide or tirzepatide can be considered external 'simulators' or 'mimics' of the GLP-1 hormone, whereas the Amarasate in Calocurb is a 'stimulant' of our own internal GLP-1
Many people use both for a balanced approach
These arrangements compromise safety and often indicate broader quality issues